SBIR-STTR Award

Metabolic Reconstruction of the Genome of Bacillus Anthracis
Award last edited on: 3/12/2003

Sponsored Program
STTR
Awarding Agency
DOD : DARPA
Total Award Amount
$599,000
Award Phase
2
Solicitation Topic Code
ST99-002
Principal Investigator
Veronika Vonstein

Company Information

Igenbio Inc (AKA: Integrated Genomics, Inc.)

1016 West Jackson Boulevard Suite 411
Chicago, IL 60607
   (312) 733-8485
   N/A
   www.igenbio.com

Research Institution

----------

Phase I

Contract Number: ----------
Start Date: ----    Completed: ----
Phase I year
1999
Phase I Amount
$99,000
The goal of the proposed research is to provide a biologically rational approach to detection of Bacillus anthracis and protection from its toxicity. The basis of the approach is extensive sequencing of the genomic DNA, including plasmids, of B. anthracis (two strains of 78 known) as well as the genome of B. cereus, the closest known relative. For sequencing, each strain will be grown under suitable safety conditions and total DNA extracted using a protocol established successfully at IG for a wide range of bacterial. Three highly random, sized DNA libraries will be constructed: 2-kb plasmid inserts, 4-kb plasmid inserts, and 35-kb cosmid inserts. Some hybridization reactions with arrays of plasmids will probably be required to cover the same regions of all three strains. This much can be accomplished under Phase I. Preliminary sequencing (20,000-20,000 runs, equal to 3x coverage of a 3-Mb genome) of plasmid and cosmid insert ends will verify the degree of relatedness among the three strains. This should be sufficient to hit about 95% of all ORFs, and match 50-70% of them. These ORFs will be integrated in a Web shell with a set of analytical tools as has been done for Rhodobacter capsulatus. We will also collect biochemical references related to B. anthracis and transfer them into the EMP format to add specific metabolic pathways for subsequent metabolic reconstruction. The remaining sequencing, editing, alignment, annotation and metabolic reconstruction will require Phase II funding. In Phase II, we will generate polished, unambiguous genome sequence. We will also integrate it into our WIT-pro/EMP analytical environment and subject it to the various clustering algorithms to verify functional predictions. At the end of the day, we expect to provide targets, based on the sequence, for detection and prevention of anthrax.

Keywords:
Genomics; Metabolic Reconstruction, Bacterial Pathogens

Phase II

Contract Number: ----------
Start Date: ----    Completed: ----
Phase II year
2001
Phase II Amount
$500,000
Comparative genomics is an efficient approach to characterize a range of pathogenic properties, from sporulation and pathogenicity factors to the evolution of multi-drug resistance caused by high affinity transport and ion efflux pump systems. IG's WIT-ProTM and "Informatics Workbench" are an optimal system for such studies. In Phase I, we completed the gapped sequence of B. cereus with 4.1x redundancy. 6300 ORFs were predicted, compared with IG's database, and subjected to automate functional assignment in WIT-ProTM, which also connects the protein products they encode to potential metabolic pathways. In Phase II, we will generate a polished sequence of B. cereus and perform comparative genomic analyses with B. anthraces and B. thuringiensis. We will increase the coverage of B. cereus to 8 fold, and perform primer walking. We will integrate the final sequence into our WIT ProTM environment and apply various algorithms to verify the automated functional predictions. We will also generate a gapped sequence of B. thuringiensis. We will compare these two sequences with the DNA sequence of B. anthraces generated by TIGR, using our specialized set of software tools to reveal the specific features of B. anthraces and to generate a functional overview of this group of organisms. Integrating these organisms into our genome database, MicrobAceTM, consisting of 19 organisms sequenced at IG, 80 complete or nearly complete public genomes, and sequence data from another 200 organisms (~440,000 ORFs), will improve the database quality since members from a very under-represented taxonomic group will be included. In addition, the comparative analysis of B. anthraces should reveal important species and strain differences related to the pathogenicity of this organism.

Keywords:
Comparative Genomics; Metabolic Reconstruction; Bacterial